Duvelisib Patent Expiration
Duvelisib is Used for treating chronic lymphocytic leukemia, small lymphocytic leukemia, and follicular lymphoma. It was first introduced by Secura Bio Inc
Duvelisib Patents
Given below is the list of patents protecting Duvelisib, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Copiktra | USRE46621 | Processes for preparing isoquinolinones and solid forms of isoquinolinones | May 17, 2032 | Secura |
| Copiktra | US11312718 | Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one | Jan 10, 2032 | Secura |
| Copiktra | US9840505 | Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereof | Jan 10, 2032 | Secura |
| Copiktra | US8193182 | Substituted isoquinolin-1(2H)-ones, and methods of use thereof | Feb 13, 2030 | Secura |
| Copiktra | US9216982 | Certain chemical entities, compositions and methods | Jan 05, 2029 | Secura |
Duvelisib's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List